US Bancorp
PRCT icon

US Bancorp’s Procept Biorobotics PRCT Stock Holding History

US Bancorp’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$285K Buy
12,618
+3,042
+32% +$76.2K ﹤0.01% 1920
2026
Q1 		$239K Sell
9,576
-11,114
-54% -$313K ﹤0.01% 1920
2025
Q4 		$651K Buy
20,690
+18,997
+1,122% +$630K ﹤0.01% 1397
2025
Q3 		$60.4K Buy
1,693
+1,079
+176% +$49.3K ﹤0.01% 2588
2025
Q2 		$35.4K Sell
614
-598
-49% -$33.8K ﹤0.01% 2941
2025
Q1 		$70.6K Sell
1,212
-146
-11% -$9.97K ﹤0.01% 2569
2024
Q4 		$109K Sell
1,358
-922
-40% -$78.8K ﹤0.01% 2352
2024
Q3 		$183K Buy
2,280
+11
+0.5% +$781 ﹤0.01% 2087
2024
Q2 		$139K Buy
2,269
+833
+58% +$49.5K ﹤0.01% 2189
2024
Q1 		$71K Buy
1,436
+83
+6% +$3.95K ﹤0.01% 2524
2023
Q4 		$56.7K Buy
1,353
+69
+5% +$2.35K ﹤0.01% 2610
2023
Q3 		$42.1K Buy
1,284
+83
+7% +$2.83K ﹤0.01% 2525
2023
Q2 		$42.5K Sell
1,201
-73
-6% -$2.41K ﹤0.01% 2584
2023
Q1 		$36.2K Buy
1,274
+247
+24% +$8.71K ﹤0.01% 2681
2022
Q4 		$42.7K Buy
1,027
+66
+7% +$2.83K ﹤0.01% 2619
2022
Q3 		$40K Sell
961
-165
-15% -$6.58K ﹤0.01% 2670
2022
Q2 		$37K Buy
+1,126
New +$41K ﹤0.01% 2748

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

US Bancorp's PRCT Position: Q2 2026 in Review

US Bancorp increased its Procept Biorobotics (PRCT) stake by 32% in Q2 2026, buying an estimated $76.2K and bringing the position to 12,618 shares worth $285K. The position accounts for ﹤0.01% of the portfolio, ranked #1920.

US Bancorp first reported a position in PRCT in Q2 2022 and has held it in 17 quarters since. The position peaked at $651K in Q4 2025. 254 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • US Bancorp held 12,618 shares of Procept Biorobotics worth $285K as of Q2 2026.
  • US Bancorp bought 3,042 Procept Biorobotics shares in Q2 2026, an estimated $76.2K.
  • Procept Biorobotics made up ﹤0.01% of US Bancorp's portfolio in Q2 2026, its #1920 holding.
  • US Bancorp first reported a position in Procept Biorobotics in Q2 2022 and has held it in 17 quarters since.
  • US Bancorp's Procept Biorobotics position peaked at $651K in Q4 2025.
  • 254 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.